BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/3/2025 8:25:32 AM | Browse: 4 | Download: 12
Publication Name World Journal of Gastrointestinal Pharmacology and Therapeutics
Manuscript ID 103232
Country China
Received
2024-11-25 13:49
Peer-Review Started
2024-11-25 13:50
To Make the First Decision
Return for Revision
2025-02-13 03:40
Revised
2025-02-26 16:53
Second Decision
2025-03-17 02:38
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief
2025-03-17 09:12
Articles in Press
2025-03-17 09:12
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2025-05-28 01:40
Publish the Manuscript Online
2025-06-03 08:25
ISSN 2150-5349 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Editorial
Article Title Nalbuphine vs sufentanil as effective analgesics for postoperative pain management in gastric cancer resection
Manuscript Source Invited Manuscript
All Author List Wei-Xiang Wang, Fu-Lin Dang, Ting-Ting Li and Yue Yu
ORCID
Author(s) ORCID Number
Yue Yu http://orcid.org/0000-0001-7905-6733
Funding Agency and Grant Number
Funding Agency Grant Number
National Natural Science Foundation of China No. 82404612
Corresponding Author Yue Yu, Associate Professor, PhD, Department of Pharmacy and Fujian Center for New Drug Safety Evaluation, Fujian Medical University, No. 1 Xuefu North Road, New District, Fuzhou 350013, Fujian Province, China. yyu@fjmu.edu.cn
Key Words Nalbuphine; Sufentanil; Postoperative pain management; Radical gastrectomy; Multimodal analgesia; Enhanced recovery after surgery
Core Tip Enhanced recovery after surgery (ERAS) protocols emphasize optimal pain management while minimizing opioid-related complications. This editorial highlights the comparative efficacy and safety profile of nalbuphine vs sufentanil in postoperative pain management following radical gastrectomy. The study demonstrates nalbuphine's advantages in terms of pain control, reduced inflammatory response, and fewer adverse events. Particularly noteworthy is its potential role in multimodal analgesia within ERAS protocols, offering a promising alternative for optimizing postoperative recovery while minimizing opioid-related complications.
Publish Date 2025-06-03 08:25
Citation <p>Wang WX, Dang FL, Li TT, Yu Y. Nalbuphine vs sufentanil as effective analgesics for postoperative pain management in gastric cancer resection. <i>World J Gastrointest Pharmacol Ther</i> 2025; 16(2): 103232</p>
URL https://www.wjgnet.com/2150-5349/full/v16/i2/103232.htm
DOI https://dx.doi.org/10.4292/wjgpt.v16.i2.103232
Full Article (PDF) WJGPT-16-103232-with-cover.pdf
Manuscript File 103232_Auto_Edited_081354.docx
Answering Reviewers 103232-answering-reviewers.pdf
Audio Core Tip 103232-audio.mp3
Conflict-of-Interest Disclosure Form 103232-conflict-of-interest-statement.pdf
Copyright License Agreement 103232-copyright-assignment.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s) 103232-foundation-statement.pdf
Non-Native Speakers of English Editing Certificate 103232-non-native-speakers.pdf
Peer-review Report 103232-peer-reviews.pdf
Scientific Misconduct Check 103232-scientific-misconduct-check.png
Scientific Editor Work List 103232-scientific-editor-work-list.pdf
CrossCheck Report 103232-crosscheck-report.pdf